Department of Health and Social Care

We support ministers in leading the nation’s health and social care to help people live more independent, healthier lives for longer.



Secretary of State

 Portrait

Sajid Javid
Secretary of State for Health and Social Care

Shadow Ministers / Spokeperson
Liberal Democrat
Daisy Cooper (LDEM - St Albans)
Liberal Democrat Spokesperson (Health and Social Care)

Democratic Unionist Party
Jim Shannon (DUP - Strangford)
Shadow DUP Spokesperson (Health)

Scottish National Party
Martyn Day (SNP - Linlithgow and East Falkirk)
Shadow SNP Spokesperson (Health and Social Care)

Labour
Wes Streeting (LAB - Ilford North)
Shadow Secretary of State for Health and Social Care
Baroness Wheeler (LAB - Life peer)
Shadow Spokesperson (Health and Social Care)
Baroness Merron (LAB - Life peer)
Shadow Spokesperson (Health and Social Care)

Plaid Cymru
Ben Lake (PC - Ceredigion)
Shadow PC Spokesperson (Health and Social Care)

Liberal Democrat
Baroness Brinton (LDEM - Life peer)
Liberal Democrat Lords Spokesperson (Health)

Scottish National Party
Lisa Cameron (SNP - East Kilbride, Strathaven and Lesmahagow)
Shadow SNP Spokesperson (Mental Health)

Labour
Baroness Thornton (LAB - Life peer)
Shadow Spokesperson (Health)
Junior Shadow Ministers / Deputy Spokesperson
Labour
Rosena Allin-Khan (LAB - Tooting)
Shadow Minister (Mental Health)
Liz Kendall (LAB - Leicester West)
Shadow Minister (Health and Social Care)
Feryal Clark (LAB - Enfield North)
Shadow Minister (Health and Social Care)
Andrew Gwynne (LAB - Denton and Reddish)
Shadow Minister (Health and Social Care)
Karin Smyth (LAB - Bristol South)
Shadow Minister (Health and Social Care)
Ministers of State
Gillian Keegan (CON - Chichester)
Minister of State (Department of Health and Social Care)
Edward Argar (CON - Charnwood)
Minister of State (Department of Health and Social Care)
Parliamentary Under-Secretaries of State
Maggie Throup (CON - Erewash)
Parliamentary Under-Secretary (Department of Health and Social Care)
Maria Caulfield (CON - Lewes)
Parliamentary Under-Secretary (Department of Health and Social Care)
Lord Kamall (CON - Life peer)
Parliamentary Under-Secretary (Department of Health and Social Care)
Scheduled Event
Wednesday 18th May 2022
14:00
Health and Social Care Committee - Oral evidence - Select & Joint Committees
18 May 2022, 2 p.m.
The future of General Practice
View calendar
Scheduled Event
Tuesday 24th May 2022
09:45
Health and Social Care Committee - Private Meeting - Select & Joint Committees
24 May 2022, 9:45 a.m.

View calendar
Scheduled Event
Tuesday 14th June 2022
11:30
Department of Health and Social Care
Oral questions - Main Chamber
14 Jun 2022, 11:30 a.m.
Health and Social Care (including Topical Questions)
Save to Calendar
View calendar
Select Committee Docs
Tuesday 17th May 2022
10:34
Select Committee Inquiry
Friday 13th May 2022
Digital transformation in the NHS

The Committee has launched a new inquiry focusing on digital transformation in the NHS.  The inquiry will explore the current …

Written Answers
Wednesday 18th May 2022
Midwives
To ask the Secretary of State for Health and Social Care, what steps he is taking to improve recruitment and …
Secondary Legislation
Monday 16th May 2022
Food and Feed (Fukushima Restrictions) (Revocation) (England) Regulations 2022
These Regulations revoke Commission Implementing Regulation (EU) 2016/6 imposing special conditions governing the import of feed and food originating in …
Bills
Tuesday 6th July 2021
Health and Care Act 2022
A Bill to make provision about health and social care.
Dept. Publications
Wednesday 18th May 2022
10:10
Treaty
None available

Department of Health and Social Care Commons Appearances

Oral Answers to Questions is a regularly scheduled appearance where the Secretary of State and junior minister will answer at the Dispatch Box questions from backbench MPs

Other Commons Chamber appearances can be:
  • Urgent Questions where the Speaker has selected a question to which a Minister must reply that day
  • Adjornment Debates a 30 minute debate attended by a Minister that concludes the day in Parliament.
  • Oral Statements informing the Commons of a significant development, where backbench MP's can then question the Minister making the statement.

Westminster Hall debates are performed in response to backbench MPs or e-petitions asking for a Minister to address a detailed issue

Written Statements are made when a current event is not sufficiently significant to require an Oral Statement, but the House is required to be informed.


Bills currently before Parliament

Department of Health and Social Care does not have Bills currently before Parliament


Acts of Parliament created in the 2019 Parliament


A Bill to make provision about health and social care.

This Bill received Royal Assent on Thursday 28th April 2022 and was enacted into law.


A Bill to confer power to amend or supplement the law relating to human medicines, veterinary medicines and medical devices; make provision about the enforcement of regulations, and the protection of health and safety, in relation to medical devices; and for connected purposes.

This Bill received Royal Assent on Thursday 11th February 2021 and was enacted into law.


A Bill to make provision in connection with coronavirus; and for connected purposes.

This Bill received Royal Assent on Wednesday 25th March 2020 and was enacted into law.


To make provision regarding the funding of the health service in England in respect of each financial year until the financial year that ends with 31 March 2024.

This Bill received Royal Assent on Monday 16th March 2020 and was enacted into law.

Department of Health and Social Care - Secondary Legislation

These Regulations revoke Commission Implementing Regulation (EU) 2016/6 imposing special conditions governing the import of feed and food originating in or consigned from Japan following the accident at the Fukushima nuclear power station and repealing Implementing Regulation (EU) No 322/2014; Commission Implementing Regulation (EU) 2017/2058 amending Implementing Regulation (EU) 2016/6 imposing special conditions governing the import of feed and food originating in or consigned from Japan following the accident at the Fukushima nuclear power station and Commission Implementing Regulation (EU) 2019/1787 amending Implementing Regulation (EU) 2016/6 imposing special conditions governing the import of feed and food originating in or consigned from Japan following the accident at the Fukushima nuclear power station all of which provided for enhanced controls on the import of certain feed and food from Japan as a result of the Fukushima nuclear accident.
The National Health Service Commissioning Board and Clinical Commissioning Groups (Responsibilities and Standing Rules) Regulations 2012 (S.I. 2012/2996) (“Standing Rules”) make provision for, amongst other things, NHS funded nursing care.
View All Department of Health and Social Care Secondary Legislation

Petitions

e-Petitions are administered by Parliament and allow members of the public to express support for a particular issue.

If an e-petition reaches 10,000 signatures the Government will issue a written response.

If an e-petition reaches 100,000 signatures the petition becomes eligible for a Parliamentary debate (usually Monday 4.30pm in Westminster Hall).

Trending Petitions
Petition Open
4,092 Signatures
(1,002 in the last 7 days)
Petition Open
74,765 Signatures
(565 in the last 7 days)
Petition Open
13,120 Signatures
(284 in the last 7 days)
Petition Open
1,955 Signatures
(254 in the last 7 days)
Petitions with most signatures
Petition Open
74,765 Signatures
(565 in the last 7 days)
Petition Open
33,897 Signatures
(72 in the last 7 days)
Petition Open
27,257 Signatures
(98 in the last 7 days)
Petition Debates Contributed

Advice from the JCVI on the priority groups for a Covid-19 vaccine does not include school/childcare workers. This petition calls for these workers, who cannot distance or use PPE, to be kept safe at work by being put on the vaccine priority list when such a list is adopted into government policy.

We want the Government to commit to not rolling out any e-vaccination status/immunity passport to the British public. Such passports could be used to restrict the rights of people who have refused a Covid-19 vaccine, which would be unacceptable.

I want the Government to prevent any restrictions being placed on those who refuse to have any potential Covid-19 vaccine. This includes restrictions on travel, social events, such as concerts or sports. No restrictions whatsoever.

View All Department of Health and Social Care Petitions

Departmental Select Committee

Health and Social Care Committee

Commons Select Committees are a formally established cross-party group of backbench MPs tasked with holding a Government department to account.

At any time there will be number of ongoing investigations into the work of the Department, or issues which fall within the oversight of the Department. Witnesses can be summoned from within the Government and outside to assist in these inquiries.

Select Committee findings are reported to the Commons, printed, and published on the Parliament website. The government then usually has 60 days to reply to the committee's recommendations.


11 Members of the Health and Social Care Committee
Jeremy Hunt Portrait
Jeremy Hunt (Conservative - South West Surrey)
Health and Social Care Committee Chair since 29th January 2020
Laura Trott Portrait
Laura Trott (Conservative - Sevenoaks)
Health and Social Care Committee Member since 2nd March 2020
Dean Russell Portrait
Dean Russell (Conservative - Watford)
Health and Social Care Committee Member since 2nd March 2020
Sarah Owen Portrait
Sarah Owen (Labour - Luton North)
Health and Social Care Committee Member since 2nd March 2020
Taiwo Owatemi Portrait
Taiwo Owatemi (Labour - Coventry North West)
Health and Social Care Committee Member since 2nd March 2020
Luke Evans Portrait
Luke Evans (Conservative - Bosworth)
Health and Social Care Committee Member since 2nd March 2020
Rosie Cooper Portrait
Rosie Cooper (Labour - West Lancashire)
Health and Social Care Committee Member since 2nd March 2020
Paul Bristow Portrait
Paul Bristow (Conservative - Peterborough)
Health and Social Care Committee Member since 2nd March 2020
Barbara Keeley Portrait
Barbara Keeley (Labour - Worsley and Eccles South)
Health and Social Care Committee Member since 11th May 2020
Lucy Allan Portrait
Lucy Allan (Conservative - Telford)
Health and Social Care Committee Member since 3rd November 2021
Martyn Day Portrait
Martyn Day (Scottish National Party - Linlithgow and East Falkirk)
Health and Social Care Committee Member since 5th January 2022
Health and Social Care Committee: Upcoming Events
Health and Social Care Committee - Oral evidence
The future of General Practice
18 May 2022, 2 p.m.
At 2.15pm: Oral evidence
Dr Pauline Grant - General Practitioner at Cheviot Road Surgery
Dr Jacob Lee - General Practitioner at Horfield Health Centre
At 3.00pm: Oral evidence
Professor Steinar Hunskår - Professor of Primary Care at University of Bergen
Dr Rebecca Rosen - Senior Fellow at Nuffield Trust
Dr Kate Sidaway-Lee - Research Fellow at St Leonard's Medical Practice

View calendar
Health and Social Care Committee - Private Meeting
24 May 2022, 9:45 a.m.
View calendar

50 most recent Written Questions

(View all written questions)
Written Questions can be tabled by MPs and Lords to request specific information information on the work, policy and activities of a Government Department

12th May 2022
To ask the Secretary of State for Health and Social Care, how many calls Op COURAGE has received each month from October 2021.

The following table shows the number of referrals received by Op COURAGE in each month from October 2021 to March 2022. Data from April 2022 is not yet available.

Month of referral

Number of referrals

October 2021

490

November 2021

560

December 2021

436

January 2022

489

February 2022

505

March 2022

520

Gillian Keegan
Minister of State (Department of Health and Social Care)
13th May 2022
To ask the Secretary of State for Health and Social Care, what assessment he has made of the adequacy of the current sick pay policy for care home staff who are absent due to covid-19.

The majority of staff working in the social care sector are employed by private providers which determine pay and the terms and conditions of employment. All providers should support good health and safety practice and employers should ensure staff stay away from the workplace where there would be a health risk to those in their care.

Statutory Sick Pay is available to those infected by COVID-19 and are unable to work, payable after four days. It is paid at £99.35 per week and is available in all sectors to those who earn more than £123 a week on average.

Gillian Keegan
Minister of State (Department of Health and Social Care)
10th May 2022
To ask the Secretary of State for Health and Social Care, how much the NHS has spent on agency and locum staff in York in each of the last five years.

This information is not held in the format requested.

Edward Argar
Minister of State (Department of Health and Social Care)
11th May 2022
To ask the Secretary of State for Health and Social Care, what estimate his Department has made of the average waiting time for an ambulance in the regional health authority area that covers the Hendon constituency in the latest period for which data is available.

The information is not collected in the format requested. Response times are not measured by regional health authority area and the average waiting time for an ambulance is not collected centrally.

Edward Argar
Minister of State (Department of Health and Social Care)
11th May 2022
To ask the Secretary of State for Health and Social Care, when he plans to respond to the letters of 4 January and 1 February 2022 from the hon. Member for Weston-super-Mare on behalf of a constituent, Ms. Roxanne Blackmore.

We replied to the hon. Member on 16 May.

Edward Argar
Minister of State (Department of Health and Social Care)
11th May 2022
To ask the Secretary of State for Health and Social Care, what proportion of the total adult social care budget has been spent on people with neurological conditions annually from 2013-14 to 2020-21; and if he will make a statement.

The data is not collected in the format requested as NHS Digital’s data does not show neurological conditions recorded as a primary support reason.

Gillian Keegan
Minister of State (Department of Health and Social Care)
10th May 2022
To ask the Secretary of State for Health and Social Care, what assessment his Department has made of the efficacy of infection prevention and control measures in social care settings as of 10 May 2022; and if he will make a statement.

No specific assessment has been made. On 31 March 2022, we issued updated guidance on infection prevention and control measures. This includes advice on personal protective equipment, testing and hand hygiene. These measures balance the risk of COVID-19 transmission in care settings, maintain protections for care recipients and aim to avoid restrictions on residents’ movement and activities as far as possible.

Gillian Keegan
Minister of State (Department of Health and Social Care)
10th May 2022
To ask the Secretary of State for Health and Social Care, what recent steps his Department has taken to help ensure that high standards of infection prevention and control are implemented consistently across social care settings.

In November 2021, the Department launched the IPC Champions Network for Adult Social Care, a forum for infection prevention and control (IPC) experts in the sector to share best practice. Accompanying the launch, the Department created a guide providing examples of IPC measures and best practice in various care settings. On 31 March 2022, we also published updated IPC guidance supported by webinars hosted by the Chief Nurse for Adult Social Care.

Gillian Keegan
Minister of State (Department of Health and Social Care)
10th May 2022
To ask the Secretary of State for Health and Social Care, with reference to the Answer of 29 September 2021 to Question 50151 on Dementia: Diagnosis, what recent assessment he has made of the impact of the £17 million to NHS England and NHS improvement on improving dementia diagnosis.

No formal assessment has yet been made. NHS England and NHS Improvement continue to monitor the monthly diagnosis rate and are analysing trends at regional and sustainability and transformation partnership level to aid targeted efforts to improve dementia diagnosis rates in 2022/23.

We will set out plans for dementia in England later this year. The strategy will focus on the health and care needs of people living with dementia and their carers, including dementia diagnoses.

Gillian Keegan
Minister of State (Department of Health and Social Care)
12th May 2022
To ask the Secretary of State for Health and Social Care, whether he plans to rollout a further covid-19 school vaccine programme to ensure that all eligible school children are vaccinated including those who were isolating or had recent infection when the previous school covid-19 vaccination programme was operating.

In December 2021, all School Aged Immunisation Service providers in England were asked to deliver in-school COVID-19 vaccinations to 12 to 15 year olds starting in the 2022 spring term. It was expected most schools would require multiple visits to ensure children who had recently contracted COVID-19 had the opportunity to be vaccinated.

An out-of-school offer is also in place for eligible children and young people. The majority of five to 11 year olds will receive their vaccination at local centres or community pharmacies outside of school hours. These appointments are available through the National Booking System or via 119 and walk-in sites remain open.

Maggie Throup
Parliamentary Under-Secretary (Department of Health and Social Care)
11th May 2022
To ask the Secretary of State for Health and Social Care, how many individual providers of NHS services will be reporting data on the 2022/23 CCG2 CQUIN: Appropriate antibiotic prescribing for UTI in adults aged 16+ from 1 April 2022.

NHS England and NHS Improvement expect that all providers commissioned to deliver acute services in England will submit this data.

Maggie Throup
Parliamentary Under-Secretary (Department of Health and Social Care)
12th May 2022
To ask the Secretary of State for Health and Social Care, if he will make available free covid-19 tests for people visiting friends and family in (a) hospitals and (b) care homes.

Most visitors are no longer required to test before entering a care setting. Visitors to hospitals and care homes are asked to take necessary precautions to keep themselves and their loved ones safe, in line with the guidance for the general population.

Visitors who provide personal care to care home residents may be asked to test before entering, up to twice weekly if visiting more than twice, with free lateral flow device tests available. Symptomatic testing continues to be available for those in social care settings.

Maggie Throup
Parliamentary Under-Secretary (Department of Health and Social Care)
11th May 2022
To ask the Secretary of State for Health and Social Care, what recent assessment he has made of his policy to end free access to lateral flow tests for visiting people in care homes on (a) the distributional impact of the costs of such tests for those visiting loved ones and (b) the rates of covid-19 (i) infection, (ii) illness and (iii) death among care home residents; and whether the Government will consider revising this policy.

The Department of Health and Social Care has indicated that it will not be possible to answer this question within the usual time period. An answer is being prepared and will be provided as soon as it is available.

Gillian Keegan
Minister of State (Department of Health and Social Care)
10th May 2022
To ask the Secretary of State for Health and Social Care, what assessment his Department has made of (a) the recovery of UK clinical cancer research following covid-19 and (b) how that recovery compares with other leading scientific nations.

In 2021/22, the National Institute for Health and Care Research’s Clinical Research Network recruited 73,691 participants across 1,060 cancer studies and established 412 new cancer studies. This compares to 1,191 clinical trials in 2019/20. Data from the Association of the British Pharmaceutical Industry shows variable recovery of commercial clinical research in other nations. As of July 2021, the United Kingdom’s monthly rate of enrolments for commercial studies across all speciality areas had reduced by 41.7% from the 2019 baseline. This compares to a 41.5% reduction in France, 44.3% in Germany and 21.7% in Italy while Spain reported an increase of 6.3%.

Maria Caulfield
Parliamentary Under-Secretary (Department of Health and Social Care)
11th May 2022
To ask the Secretary of State for Health and Social Care, what steps he is taking to improve incidental diagnosis rate of heart valve disease following the reduction of face-to-face GP appointments.

NHS England and NHS Improvement’s guidance states that general practitioner practices must provide face to face appointments, alongside remote consultations. Patients’ views should be sought and practices should respect preferences for face to face care unless there are good clinical reasons to the contrary. In March 2022, 62% of appointments were face-to-face, excluding COVID-19 vaccinations. At the end of 2021/22, 66 community diagnostic centres were available to support Primary Care Networks to increase diagnostic capacity and improve the detection of conditions such as heart failure and heart valve disease.

Maria Caulfield
Parliamentary Under-Secretary (Department of Health and Social Care)
12th May 2022
To ask the Secretary of State for Health and Social Care, whether his Department plans to collect data on the costs of aftercare to the NHS, for patients who report adverse effects following (a) aesthetic and (b) cosmetic procedures.

We have no current plans to do so. However, as part of the introduction of a licensing scheme for non-surgical cosmetic procedures in England, the Department will work with stakeholders to collate data and gather evidence on the incidence of consumers seeking treatment through the National Health Service for complications following private cosmetic procedures.

Maria Caulfield
Parliamentary Under-Secretary (Department of Health and Social Care)
11th May 2022
To ask the Secretary of State for Health and Social Care, what assessment he has made of the (a) availability and (b) accessibility of Sotrovimab in (i) Slough and (ii) England.

Patient access to sotrovimab is clinically determined in line with the published clinical access policies. Individuals at highest risk from COVID-19 infection can access this treatment directly from COVID Medicines Delivery Units (CMDUs) or via the RECOVERY trial for patients admitted to hospital with COVID-19. The latest data shows that 24,798 patients who tested positive for COVID-19 have received sotrovimab in England, with the majority of these patients receiving treatment as non-hospitalised patients via a CMDU.

While the information relating to Slough is not held in the format requested, 2,175 patients suitable for treatment have been identified in the Frimley CDMU area, of whom 701 have been triaged for and treated with sotrovimab and 343 have received oral antiviral medication.

Maggie Throup
Parliamentary Under-Secretary (Department of Health and Social Care)
12th May 2022
To ask the Secretary of State for Health and Social Care, with reference to the Answer of 25 April 2022 to Question 154082 on Kidney Diseases, how that information is held.

The National Health Service Electronic Staff Record does not identify renal counsellors as a staff group. Local NHS organisations will record the number of staff specifically identified as renal counsellors, although definitions of roles and responsibilities may differ between locations.

Edward Argar
Minister of State (Department of Health and Social Care)
10th May 2022
To ask the Secretary of State for Health and Social Care, what assessment the Government has made of the potential merits of reversing compulsory covid-19 vaccination requirements in all sectors that contain them.

Following a public consultation, the legislation to revoke vaccination requirements for all sectors came into force on 15 March 2022.

Edward Argar
Minister of State (Department of Health and Social Care)
11th May 2022
To ask the Secretary of State for Health and Social Care, with reference to the Answer of 28 April 2022 to Question 141960, what progress has been made on assessing Evusheld for treating immunocompromised patients.

The UK Health Security Agency has yet to complete testing on Evusheld’s efficacy against the Omicron variant. The timing of these results is dependent on the testing assays being completed successfully, which will inform any decisions on potential deployment.

Maggie Throup
Parliamentary Under-Secretary (Department of Health and Social Care)
11th May 2022
To ask the Secretary of State for Health and Social Care, with reference to the Answer of 28 March 2022 to Question 141960, when he expects patients in the UK to have access to Evusheld as a preventative treatment for covid-19.

The UK Health Security Agency has yet to complete testing on Evusheld’s efficacy against the Omicron variant. The timing of these results is dependent on the testing assays being completed successfully, which will inform any decisions on potential deployment.

Maggie Throup
Parliamentary Under-Secretary (Department of Health and Social Care)
11th May 2022
To ask the Secretary of State for Health and Social Care, what plans he has to introduce covid-19 passports for children aged between five and 11 years.

Since 28 April 2022, the NHS COVID Pass travel letter has been available for five to 11 year olds who have received a full primary course of vaccination. A parent or guardian can request the letter via NHS.UK or 119. We are currently reviewing the provision of evidence of prior infection or recovery and a digital option.

Maggie Throup
Parliamentary Under-Secretary (Department of Health and Social Care)
11th May 2022
To ask the Secretary of State for Health and Social Care, how many complaints have been made to the managed quarantine service on refunds for unused days of quarantine since 1 January 2021.

The information is not held in the format requested.

Maggie Throup
Parliamentary Under-Secretary (Department of Health and Social Care)
11th May 2022
To ask Her Majesty's Government what assessment they have made of the (1) impact on technology appraisals, and (2) timely access to medicines, of current capacity issues experienced by the National Institute for Health and Care Excellence.

The National Institute for Health and Care Excellence (NICE) commits to publishing draft recommendations on new medicines approximately at the time of licensing, with final guidance within three months of licensing wherever possible. In 2021/22, guidance was issued within three months of a licence for 100% of new medicines where NICE proceeded to appraisal and 98 technology appraisals were published, meeting the target in its business plan.

The Department holds regular accountability meetings with NICE to discuss a range of issues, including the delivery of its commitments. NICE is prioritising the flexibility and capacity of its technology appraisal programme through a more proportionate approach to assessments. From April 2023, NICE aims to expand its capacity for technology appraisals by 20% to respond to the increasing numbers of topics referred for appraisal.

Lord Kamall
Parliamentary Under-Secretary (Department of Health and Social Care)
11th May 2022
To ask Her Majesty's Government what discussions they have held with the National Institute of Health and Care Excellence in relation to its plans to deal with capacity issues.

The National Institute for Health and Care Excellence (NICE) commits to publishing draft recommendations on new medicines approximately at the time of licensing, with final guidance within three months of licensing wherever possible. In 2021/22, guidance was issued within three months of a licence for 100% of new medicines where NICE proceeded to appraisal and 98 technology appraisals were published, meeting the target in its business plan.

The Department holds regular accountability meetings with NICE to discuss a range of issues, including the delivery of its commitments. NICE is prioritising the flexibility and capacity of its technology appraisal programme through a more proportionate approach to assessments. From April 2023, NICE aims to expand its capacity for technology appraisals by 20% to respond to the increasing numbers of topics referred for appraisal.

Lord Kamall
Parliamentary Under-Secretary (Department of Health and Social Care)
11th May 2022
To ask Her Majesty's Government what plans they have to address capacity issues being experienced by the National Institute of Health and Care Excellence.

The National Institute for Health and Care Excellence (NICE) commits to publishing draft recommendations on new medicines approximately at the time of licensing, with final guidance within three months of licensing wherever possible. In 2021/22, guidance was issued within three months of a licence for 100% of new medicines where NICE proceeded to appraisal and 98 technology appraisals were published, meeting the target in its business plan.

The Department holds regular accountability meetings with NICE to discuss a range of issues, including the delivery of its commitments. NICE is prioritising the flexibility and capacity of its technology appraisal programme through a more proportionate approach to assessments. From April 2023, NICE aims to expand its capacity for technology appraisals by 20% to respond to the increasing numbers of topics referred for appraisal.

Lord Kamall
Parliamentary Under-Secretary (Department of Health and Social Care)
10th May 2022
To ask Her Majesty's Government whether they conducted a cost analysis before the implementation of the Coronavirus Test Device Approvals process; and how the desktop review fee amount for test applications was decided.

The Department’s online only impact assessment included a cost analysis and calculations on the implementation of the Coronavirus Test Device Approvals process. It is intended that this regulation should be cost neutral for taxpayers and as such, the Government recovers the costs from applicants, while ensuring fees are as low as possible. However, through engagement in a public consultation and with industry, we recognised concerns on ensuring smaller businesses can access the market. Therefore a discounted rate of 55% is offered, in line with taxation benefits for research and development spending offered to small to medium-sized enterprises. We have committed to review the policy at the end of 2022.

Lord Kamall
Parliamentary Under-Secretary (Department of Health and Social Care)
10th May 2022
To ask Her Majesty's Government what steps they are taking to address the reported bottleneck in the Coronavirus Test Device Approval process.

Current delays in the Coronavirus Test Device Approval (CTDA) process have been due to further information being sought from applicants during the validation process. However, to ensure applications meet the required standards, expert support has been provided by officials, with 60% of approvals being processed in the last three months.

The number of scientific advisors has also been increased to meet demand. Online guidance for applicants has also been updated to provide greater clarity for acceptance criteria for the range of viral loads within positive samples. Officials continue to work with applicants to provide support during the process and minimise any potential delays.

Lord Kamall
Parliamentary Under-Secretary (Department of Health and Social Care)
11th May 2022
To ask the Secretary of State for Health and Social Care, if he will amend the prescription charge medical exemptions list to include (a) cystic fibrosis and (b) other long-term conditions.

We have no current plans to do so. Approximately 89% of prescriptions are dispensed free of charge and there are arrangements in place to help those with the greatest need. Eligibility depends on the patient’s age, whether they are in qualifying full-time education, whether they are pregnant or have recently given birth, or whether they are in receipt of certain benefits or a war pension. Those with cystic fibrosis or another long-term condition may meet the eligibility criteria for prescription charge exemptions and be in receipt of free prescriptions.

Edward Argar
Minister of State (Department of Health and Social Care)
11th May 2022
To ask the Secretary of State for Health and Social Care, what assessment he has has made of the potential merits of the development of a coeliac training programme for primary care physicians and other relevant healthcare professionals to improve understandings of the disease and support its diagnosis; and if he will make a statement.

No specific assessment has been made. The gastroenterology chapter of the Royal College of General Practitioners’ curriculum for general practitioners (GPs) in training addresses the treatment of coeliac disease. Additionally, the Royal College has made online resources are available on the topic and National Institute for Health and Care Excellence’s guidelines are tested in the Applied Knowledge Test assessment for GP training. Health Education England’s training programmes offer educational sessions on the Royal College’s curriculum for common gastroenterological conditions, which include coeliac disease assessment, investigation and management.

Edward Argar
Minister of State (Department of Health and Social Care)
11th May 2022
To ask the Secretary of State for Health and Social Care, whether his Department is taking steps to ensure that maternity staff do not undertake training on their own.

Individual National Health Service trusts are responsible for investing in post-registration training, ensuring that staff are trained and competent to carry out their role and are adequately supported throughout their training. All training undertaken by post-registration qualified staff should be in line with national and local guidelines covering the training being undertaken.

Edward Argar
Minister of State (Department of Health and Social Care)
11th May 2022
To ask the Secretary of State for Health and Social Care, which NHS Trusts conduct exit interviews for departing staff.

The information requested on trusts undertaking exit interviews is not held centrally. While exit interviews are recommended in the National Health Service learning handbook, it may not be appropriate for all staff, such as in cases of redundancy or dismissal. An updated, online, self-exit questionnaire was launched in October 2021, which includes staff survey questions and allows staff to explain their reasons for leaving. This is currently being promoted to all NHS trusts and is in use in approximately 83 organisations.

Reasons for leaving are noted in the Electronic Staff Record. Where detailed information for leaving was available, in 2021 the most frequent reasons were retirement; end of fixed term contract; work/life balance; relocation; and pay or reward.

Edward Argar
Minister of State (Department of Health and Social Care)
11th May 2022
To ask the Secretary of State for Health and Social Care, whether the findings of exit interviews by NHS Trusts for departing staff are collated centrally.

The information requested on trusts undertaking exit interviews is not held centrally. While exit interviews are recommended in the National Health Service learning handbook, it may not be appropriate for all staff, such as in cases of redundancy or dismissal. An updated, online, self-exit questionnaire was launched in October 2021, which includes staff survey questions and allows staff to explain their reasons for leaving. This is currently being promoted to all NHS trusts and is in use in approximately 83 organisations.

Reasons for leaving are noted in the Electronic Staff Record. Where detailed information for leaving was available, in 2021 the most frequent reasons were retirement; end of fixed term contract; work/life balance; relocation; and pay or reward.

Edward Argar
Minister of State (Department of Health and Social Care)
11th May 2022
To ask the Secretary of State for Health and Social Care, what evidence is used to determine the cause of early departure of staff from the NHS.

The information requested on trusts undertaking exit interviews is not held centrally. While exit interviews are recommended in the National Health Service learning handbook, it may not be appropriate for all staff, such as in cases of redundancy or dismissal. An updated, online, self-exit questionnaire was launched in October 2021, which includes staff survey questions and allows staff to explain their reasons for leaving. This is currently being promoted to all NHS trusts and is in use in approximately 83 organisations.

Reasons for leaving are noted in the Electronic Staff Record. Where detailed information for leaving was available, in 2021 the most frequent reasons were retirement; end of fixed term contract; work/life balance; relocation; and pay or reward.

Edward Argar
Minister of State (Department of Health and Social Care)
11th May 2022
To ask the Secretary of State for Health and Social Care, what the most frequent reasons are given by staff for early departure from the NHS in order of frequency.

The information requested on trusts undertaking exit interviews is not held centrally. While exit interviews are recommended in the National Health Service learning handbook, it may not be appropriate for all staff, such as in cases of redundancy or dismissal. An updated, online, self-exit questionnaire was launched in October 2021, which includes staff survey questions and allows staff to explain their reasons for leaving. This is currently being promoted to all NHS trusts and is in use in approximately 83 organisations.

Reasons for leaving are noted in the Electronic Staff Record. Where detailed information for leaving was available, in 2021 the most frequent reasons were retirement; end of fixed term contract; work/life balance; relocation; and pay or reward.

Edward Argar
Minister of State (Department of Health and Social Care)
10th May 2022
To ask the Secretary of State for Health and Social Care, when he plans to respond to the enquiry of 2 March 2022 from the hon. Member for High Peak, reference RL34456.

We replied to the hon. Member on 16 May 2022.

Edward Argar
Minister of State (Department of Health and Social Care)
11th May 2022
To ask the Secretary of State for Health and Social Care, what recent estimate he has been made of the level of funding into mental health research; and what assessment he has made of the adequacy of the level of that funding being made into that research.

The Department funds mental health research in the United Kingdom through the National Institute for Health and Care Research (NIHR).  In 2020/21, the NIHR spent £109.5 million on mental health research. We are also funding the Mental Health Research Initiative to expand current activity and build the capacity and capability of mental health research in regions which are currently underrepresented. While it is not usual practice to ring-fence funds for particular topics or conditions, the NIHR’s funding is available through open competition and we encourage researchers to submit applications in this area.

Maria Caulfield
Parliamentary Under-Secretary (Department of Health and Social Care)
11th May 2022
To ask the Secretary of State for Health and Social Care, if his Department will make an assessment of the potential merits of providing testosterone routinely within hormone replacement therapy.

The National Institute for Health and Care Excellence’s (NICE) guideline on the diagnosis and management of menopause published in 2015 recommended that testosterone supplementation should be considered for menopausal women with low sexual desire if hormone replacement therapy alone is not effective. Healthcare professionals should take NICE’s guidelines fully into account in the care and treatment of individual patients. NICE is currently updating its guideline on menopause in light of new evidence and recently consulted on the draft scope of the revised guideline.

Maria Caulfield
Parliamentary Under-Secretary (Department of Health and Social Care)
11th May 2022
To ask the Secretary of State for Health and Social Care, whether his Department is taking steps to encourage consultants to prescribe medicinal cannabis to children with severe drug resistant epilepsy.

The prescription of any medicine is a clinical decision. The Government has enabled the prescription of cannabis-based products for medicinal use (CBPMs) where it is clinically appropriate.

The licensed cannabis-based medicine Epidyolex is routinely prescribed for two forms of epilepsy. However, clinical guidelines from the National Institute for Health and Care Excellence demonstrate a clear need for further evidence to support routine prescribing and funding decisions for unlicensed CBPMs. We continue to encourage manufacturers of these products to conduct research and we are working with regulatory, research and National Health Service partners to establish clinical trials to enable evidence based prescribing decisions.

Maria Caulfield
Parliamentary Under-Secretary (Department of Health and Social Care)
11th May 2022
To ask the Secretary of State for Health and Social Care, what steps his Department is taking to support the efforts to (a) improve cancer services across the NHS and (b) find a lasting cure for cancer.

The NHS Long Term Plan committed to improve cancer services to increase the proportion of cancers diagnosed at Stage 1 and 2 to 75% by 2028. This aims to ensure that an additional 55,000 people each year will survive cancer for at least five years after their diagnosis. We are currently analysing the responses submitted through the call for evidence to develop the 10 Year Cancer Plan, which will be published later this year. The Plan will provide further detail on how we will improve cancer services.

The Department invests in health research through the National Institute for Health and Care Research (NIHR). In 2020/21, the NIHR’s expenditure on cancer research was £73.5 million. The NIHR welcomes funding applications for research into any aspect of human health, including treatments for cancer, and encourages researchers to submit high-quality research proposals in this area.

Maria Caulfield
Parliamentary Under-Secretary (Department of Health and Social Care)
11th May 2022
To ask the Secretary of State for Health and Social Care, what assessment her Department has made of the impact on women of postponing the introduction of a single annual prepayment certificate of £18.70 for HRT prescriptions until April 2023.

No specific assessment has been made. The introduction of the hormone replacement therapy prescription prepayment certificate requires significant technical changes to existing systems and processes. We are working with the NHS Business Services Authority to implement the certificate as soon as possible.

Maria Caulfield
Parliamentary Under-Secretary (Department of Health and Social Care)
11th May 2022
To ask the Secretary of State for Health and Social Care, what his Department's timetable is for (a) announcing, (b) consulting upon and (c) introducing the planned dental contract reform.

We are currently negotiating proposed changes to the National Health Service contract for dentistry services with the British Dental Association. We will set out a timetable for implementation timetable when these negotiations have concluded.

Maria Caulfield
Parliamentary Under-Secretary (Department of Health and Social Care)
11th May 2022
To ask the Secretary of State for Health and Social Care, whether his Department collects information when staff leave the midwifery profession on their reasons for leaving.

The National Health Service Electronic Staff Record (ESR) collects information through a ‘reason for leaving’ data field linked to staff recorded as leaving active service.

Edward Argar
Minister of State (Department of Health and Social Care)
11th May 2022
To ask the Secretary of State for Health and Social Care, what assessment his Department has made of the (a) socioeconomic impact and (b) impact on (i) patients and (ii) the general public of the backlog in elective procedures.

No formal assessment has been made. However, the ‘Delivery plan for tackling the COVID-19 backlog of elective care’ published in February 2022 acknowledges the impact of long waiting times for treatment on patients and their carers, National Health Service staff and on health inequalities. The plan aims to minimise the impact of the backlog and to ensure the inclusive recovery of elective services.

Edward Argar
Minister of State (Department of Health and Social Care)
10th May 2022
To ask the Secretary of State for Health and Social Care, when he expects the novavax covid-19 vaccine to be available for people in the UK.

There is no current date when we expect Novavax to be available for people in the United Kingdom. We will continue to be guided by the advice of the independent Joint Committee of Vaccination and Immunisation (JCVI) on which vaccines should be deployed in the UK’s vaccination programmes. The JCVI has discussed the potential use of Novavax’s COVID-19 vaccine (Nuvaxovid) in the national vaccination programme. Its considerations will be published in due course and kept under review.

Maggie Throup
Parliamentary Under-Secretary (Department of Health and Social Care)
10th May 2022
To ask the Secretary of State for Health and Social Care, with reference to the Answer of 28 February 2022 to Question 43901 on Coronavirus: Vaccination, if he will seek an update from the Joint Committee on Vaccination and Immunisation on the roll-out of the novavax covid-19 vaccine in the UK.

There is no current date when we expect Novavax to be available for people in the United Kingdom. We will continue to be guided by the advice of the independent Joint Committee of Vaccination and Immunisation (JCVI) on which vaccines should be deployed in the UK’s vaccination programmes. The JCVI has discussed the potential use of Novavax’s COVID-19 vaccine (Nuvaxovid) in the national vaccination programme. Its considerations will be published in due course and kept under review.

Maggie Throup
Parliamentary Under-Secretary (Department of Health and Social Care)
10th May 2022
To ask the Secretary of State for Health and Social Care, with reference to the suspension of the £100 million of funding for weight management services, announced on 4 March 2022, what assessment his Department has made of the impact of that suspension on other weight management services run by local authorities that were already established prior to the announcement of extra funding in 2021.

The Adult Weight Management Services Grant distributed for use in 2021/22 was in addition to local authorities’ existing expenditure on adult tier 2 behavioural weight management services from the Public Health Grant. This funding must be used to commission new or expand existing services and was not intended to replace other funding. In 2022/23, the total Public Health Grant to local authorities is £3.417 billion. Decisions on how the Public Health Grant is spent are made by individual local authorities.

Maggie Throup
Parliamentary Under-Secretary (Department of Health and Social Care)
11th May 2022
To ask the Secretary of State for Health and Social Care, what research is being undertaken on the combined effects of risperidone and covid-19 vaccines; and whether that research will be published.

The Department commissions research through the National Institute for Health and Care Research (NIHR). The NIHR is not currently supporting any specific research on the combined effects of risperidone and COVID-19 vaccines. The NIHR welcomes funding applications for research into any aspect of human health, including effects of COVID-19 vaccination.

Maggie Throup
Parliamentary Under-Secretary (Department of Health and Social Care)
12th May 2022
To ask the Secretary of State for Health and Social Care, what steps he is taking to limit the risk of covid-19 in care homes from visitors.

We have published guidance on infection prevention and control in adult social care settings which encourages visitors to take necessary precautions. This includes wearing face masks and staying away from the care home if they are symptomatic or test positive for COVID-19. Visitors providing personal care are advised to test themselves up to twice weekly before entering the care home, with free asymptomatic testing available.

Gillian Keegan
Minister of State (Department of Health and Social Care)